Description

BSE announces listing of new Commercial Papers issued by Motilal Oswal Financial Services Limited worth Rs. 100 crore on private placement basis, effective November 18, 2025.

Summary

BSE has listed new Commercial Paper securities issued by Motilal Oswal Financial Services Limited on private placement basis. The securities are admitted to dealings on the BSE Debt segment effective November 18, 2025. A total of 2,000 Commercial Papers of face value Rs. 5,00,000 each (totaling Rs. 100 crore) have been listed.

Key Points

  • Securities: Commercial Paper of Rs. 5,00,000 each
  • Total Quantity: 2,000 units (Rs. 100 crore aggregate)
  • Scrip Code: 729763
  • Scrip ID: MOFSL2725A
  • Detail Name: MOFSL-27-05-26-CP
  • ISIN: INE338I14KP9 (Further listing under same ISIN)
  • Credit Rating: ICRA A1+, IND A1+
  • Issue Price: Rs. 481,579 per unit
  • Market Lot: 1 unit
  • Allotment Date: November 17, 2025
  • Redemption Date: May 27, 2026
  • Issuing and Paying Agent: HDFC Bank Ltd
  • Trading Mode: Dematerialized form only
  • Tick Size: 1 paise

Regulatory Changes

No regulatory changes. This is a standard new listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE338I14KP9
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Trading members requiring clarification may contact BSE debt department on 22728352/8597/8995/5753/8915

Important Dates

  • Allotment Date: November 17, 2025
  • Listing Date: November 18, 2025
  • Redemption Date: May 27, 2026
  • Tenure: Approximately 6 months

Impact Assessment

This is a routine commercial paper listing with minimal market impact. It represents short-term borrowing by Motilal Oswal Financial Services Limited rated at the highest credit quality (A1+). The listing provides debt market participants additional investment options in high-rated short-term instruments. No broader market or operational changes are involved.

Impact Justification

Routine commercial paper listing announcement with no broader market implications or regulatory changes